Cellular Reprogramming

Cellular Reprogramming is a revolutionary process in biotechnology and regenerative medicine that involves the conversion of differentiated cells into a pluripotent or multipotent state, allowing them to differentiate into various cell types. This process holds immense potential for disease modelling, drug discovery, and cell-based therapies, as it enables the generation of patient-specific cells for personalized medicine approaches. One of the most well-known methods of cellular reprogramming is induced pluripotent stem cell (iPSC) technology, which involves the introduction of specific transcription factors, such as Oct4, Sox2, Klf4, and c-Myc, into differentiated cells, such as fibroblasts, to reprogram them into pluripotent stem cells. These iPSCs have the capacity to differentiate into any cell type in the body, making them valuable tools for studying disease mechanisms, screening drugs, and developing cell-based therapies. Cellular reprogramming has also been achieved through other methods, such as somatic cell nuclear transfer (SCNT) and cell fusion, which involve the transfer of a cell nucleus or fusion of cells to reset their epigenetic state and reprogram them into a pluripotent state. These approaches have been used to generate embryonic stem cell-like cells from somatic cells, providing alternative routes for cellular reprogramming. In addition to generating iPSCs, cellular reprogramming can also involve the direct conversion of one cell type into another without passing through a pluripotent state, a process known as direct reprogramming or trans differentiation.